期刊文献+

卵巢交界性肿瘤保留生育功能手术的疗效评价 被引量:2

Clinical Efficacy Evaluation of Fertility-preserving Surgery in the Treatment of Borderline Ovarian Tumors
原文传递
导出
摘要 目的探讨卵巢交界性肿瘤(borderline ovarian tumors, BOTs)患者行保留生育功能手术的临床疗效。方法回顾性分析2008年1月~2020年1月在辽宁省肿瘤医院就诊的144例BOTs患者的临床资料(包括患者年龄、手术方式、临床分期、高危因素、是否术后化疗、是否复发),分析保留生育功能手术(Fertility sparing surgery, FSS.)与根治手术(Radical surgery, RS.)的临床效果及生育情况,比较保留生育功能不同手术方式的复发率、妊娠率,用Kaplan-Meier法进行生存分析。结果所有患者中,FSS组总体复发率13.79%高于RS组总体复发率2.63%,比较有统计学差异(P=0.015)。保留生育功能不同术式的复发率比较,卵巢病损切除(包括单侧和双侧)复发率36.36%高于单侧附件切除8.11%、单侧附件+对侧卵巢病损切除10%,比较没有统计学差异(P=0.052)。FSS组3年、5年、10年生存率均为100%,中位DFS为40个月;RS组3年、5年、10年生存率为97.44%、97.96%、97.33%,中位DFS为45.5个月,两组比较无统计学差异(P=0.190)。FSS组无死亡病例,RS组2例死于肿瘤复发。FSS组1年、2年、3年妊娠率5.17%、8.62%、10.34%。结论卵巢交界性肿瘤行保留生育功能手术有复发风险,但不影响患者总生存率;妊娠率随着术后时间延长而增加。 Objective To discuss the clinical efficacy of fertility sparing surgery(FSS) in the therapy of sick person with borderline ovarian tumors(BOTs).Methods A retrospective analysis of the clinical data of 144 BOTs patients treated in Liaoning Cancer Hospital from January 2008 to January 2020(including patient age, surgical methods, clinical stage, high-risk factors, postoperative chemotherapy and recurrence),analysis of clinical efficacy and fertility condition of FSS(Including ovarian lesion resection, unilateral adnexectomy, unilateral adnexectomy + contralateral ovarian lesion resection) and radical surgery(Including bilateral appendages, total uterus + bilateral appendage resection).We were compared with the recurrence rate and pregnancy rate of different surgical methods to preserve fertility.The Kaplan-Meier method was used for survival analysis.Results Among all patients, the overall recurrence rate of the FSS group was 13.79% higher than that of the radical surgery(RS) group was 2.63%,which was statistically different(P=0.015).Comparing the recurrence rate of different surgical procedures for preserving fertility, there are no statistical differences(P=0.052).The recurrence rate of ovarian lesion resection(including unilateral and bilateral) was 36.36% higher than that of unilateral attachment resection 8.11%,and unilateral attachment + contralateral ovarian lesion resection10%.The 3 year, 5 year, and 10 year survival rates in the FSS group were all 100%,and the median DFS was 40 months;the 3 year, 5 year, and 10 year survival rates in the RS group were 97.44%,97.96%,and 97.33%,and the median DFS was 45.5 months, and there was no statistical difference between the two groups(P=0.190).There were no deaths in the FSS group, and 2 patients in the RS group died of tumor recurrence.The pregnancy rates of 1 year, 2 years and 3 years in the FSS group were 5.17%,8.62%,and 10.34%.Conclusion There is a risk of recurrence of FSS for BOTs, but it does not affect the overall survival rate of the patient;the pregnancy rate increases with the postoperative time.
作者 赵懿宁 李依桐 郑伟 张新 Zhao Yining;Li Yitong;Zheng Wei;Zhang Xin(Liaoning University of Traditional Chinese Medicine,ShenYang 110032;Cancer Hospital of China Medical University,ShenYang 110042)
出处 《辽宁医学杂志》 2021年第3期22-25,共4页 Medical Journal of Liaoning
关键词 卵巢交界肿瘤 保留生育功能 手术治疗 生存结局 Borderline ovarian tumors Fertility-preserving Surgical treatment Survival outcome
  • 相关文献

参考文献6

二级参考文献40

  • 1段微,范逢晓.保留生育功能手术对卵巢交界性肿瘤临床治疗效果的影响[J].中国实用妇科与产科杂志,2006,22(6):449-450. 被引量:11
  • 2唐军,赖娟,耿京,吕君.术前诊断卵巢交界性肿瘤的超声特征[J].中国妇产科临床杂志,2007,8(3):172-174. 被引量:18
  • 3Mikami Y. Paradigm shift in ovarian tumor pathology from the view ofgenomic abnormalities [J]. Gan To Kagaku Ryoho, 2016,43(3) :286-289.
  • 4孙但窈.卵巢交界性肿瘤病理及影响预后相关因素分析[D],乌鲁木齐:新疆医科大学.2015.
  • 5Hashmi AA, Hussain ZF,Bhagwani AR,et al. Clinico- pathologic features of ovarian neoplasms with emphasis on borderline ovarian tumors:an institutional perspective [J]. BMC Res Notes, 2016,9(1) : 205.
  • 6Li X, Yang J,Wang X, et al. Role of TWIST2, E -cad- herin and Vimentin in epithelial ovarian carcinogenesis and prognosis and their interaction in cancer progression [J]. Eur J Gynaecol Oncol, 2016,37(1 ) : 100-108.
  • 7Tiwari RK, Saha K, Mukhopadhyay D, et al. Evaluation of preoperative serum levels of CA125 and Expression of p53 in ovarian neoplasms:a prospective clinicopathologi- cal study in a Tertiary Care Hospital [J]. J Obstet Gynaeeol India, 2016,66(2) : 107-114.
  • 8Yoshida A, Derchain SF,Pitta DR,et al. Comparing the Copenhagen Index (CPH-I)and Risk of Ovarian Malig- nancy Algorithm(ROMA) :two equivalent ways to differ- entiate malignant from benign ovarian tumors before surgery? [J]. Gynecol Oncol,2016,140(3) :481-485.
  • 9梁旭东,曾浩霞,李艺,祝洪澜,沈丹华,廖晓云,崔恒,魏丽惠.卵巢交界性上皮性肿瘤临床分析[J].中国妇产科临床杂志,2010,11(6):406-409. 被引量:14
  • 10姚远洋,王悦,王建六,张震宇,孟元光,沈铿,郭红燕,李斌,吴玉梅,温洪武,张毅,赵超,魏丽惠.早期宫颈癌保留生育功能治疗后肿瘤和妊娠结局的多中心研究[J].中国妇产科临床杂志,2013,14(1):4-7. 被引量:17

共引文献56

同被引文献20

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部